• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用凝集素和新糖缀合物将药物靶向输送至结肠。

Drug targeting to the colon with lectins and neoglycoconjugates.

作者信息

Minko Tamara

机构信息

Department of Pharmaceutics, Ernest Mario School of Pharmacy Rutgers, The State University of New Jersey, 160 Frelinghuysen Road, Piscataway, NJ 08854-8020, USA.

出版信息

Adv Drug Deliv Rev. 2004 Mar 3;56(4):491-509. doi: 10.1016/j.addr.2003.10.017.

DOI:10.1016/j.addr.2003.10.017
PMID:14969755
Abstract

Targeting of drugs to specific sites of action provides several advantages over non-targeted drugs. These include the prevention of side effects of drugs on healthy tissues and enhancement of drug uptake by targeted cells. This review will cover traditional approaches of colon drug targeting as well as the use of lectins and neoglycoconjugates for the targeted delivery. Direct and reverse targeting strategies, potential molecular targets and targeting moieties for colon drug delivery, targeted drug delivery systems (DDS) for colon delivery, anticancer DDS targeted to colon cancer are examined. Directions of future development are discussed.

摘要

与非靶向药物相比,将药物靶向特定作用部位具有多个优势。这些优势包括预防药物对健康组织产生副作用以及增强靶向细胞对药物的摄取。本综述将涵盖结肠药物靶向的传统方法以及使用凝集素和新糖缀合物进行靶向递送。研究了直接和反向靶向策略、结肠药物递送的潜在分子靶点和靶向部分、用于结肠递送的靶向药物递送系统(DDS)、靶向结肠癌的抗癌DDS。并讨论了未来的发展方向。

相似文献

1
Drug targeting to the colon with lectins and neoglycoconjugates.利用凝集素和新糖缀合物将药物靶向输送至结肠。
Adv Drug Deliv Rev. 2004 Mar 3;56(4):491-509. doi: 10.1016/j.addr.2003.10.017.
2
[Site-specific drug delivery systems. I. Colon targeted delivery].[部位特异性给药系统。I. 结肠靶向给药]
Acta Pharm Hung. 2007;77(3):185-9.
3
Lectin-mediated drug delivery in the oral cavity.凝集素介导的口腔药物递送
Adv Drug Deliv Rev. 2004 Mar 3;56(4):481-9. doi: 10.1016/j.addr.2003.10.016.
4
M cell targeting by lectins: a strategy for mucosal vaccination and drug delivery.凝集素靶向M细胞:一种黏膜疫苗接种和药物递送策略。
Adv Drug Deliv Rev. 2004 Mar 3;56(4):511-25. doi: 10.1016/j.addr.2003.10.018.
5
Colonic treatments and targets: issues and opportunities.结肠治疗与靶点:问题与机遇
J Drug Target. 2009 Jun;17(5):335-63. doi: 10.1080/10611860902839502.
6
What should be considered on design of a colon-specific prodrug?设计结肠靶向前药时应考虑哪些因素?
Expert Opin Drug Deliv. 2010 Feb;7(2):245-58. doi: 10.1517/17425240903490401.
7
[Development of antituberculous drugs: current status and future prospects].[抗结核药物的研发:现状与未来前景]
Kekkaku. 2006 Dec;81(12):753-74.
8
Colonic drug targeting.结肠药物靶向
J Drug Target. 1998;6(2):129-49. doi: 10.3109/10611869808997888.
9
Colonic drug delivery: an updated review.结肠给药:最新综述。
AAPS PharmSci. 2003;5(2):E17. doi: 10.1208/ps050217.
10
Oral colon targeted delivery systems for treatment of inflammatory bowel diseases: synthesis, in vitro and in vivo assessment.用于治疗炎症性肠病的口服结肠靶向递送系统:合成、体外和体内评估
Int J Pharm. 2008 Jun 24;358(1-2):248-55. doi: 10.1016/j.ijpharm.2008.04.021. Epub 2008 Apr 20.

引用本文的文献

1
NSAID-encapsulated nanoparticles as a targeted therapeutic platform for modulating chronic inflammation and inhibiting cancer progression: a review.非甾体抗炎药包裹的纳米颗粒作为调节慢性炎症和抑制癌症进展的靶向治疗平台:综述
Inflammopharmacology. 2025 Apr 26. doi: 10.1007/s10787-025-01760-8.
2
Targeted Cancer Therapy-on-A-Chip.靶向癌症治疗芯片
Adv Healthc Mater. 2024 Nov;13(29):e2400833. doi: 10.1002/adhm.202400833. Epub 2024 Aug 5.
3
Novel insight into FCSK-congenital disorder of glycosylation through a CRISPR-generated cell model.
通过 CRISPR 生成的细胞模型对 FCSK-先天性糖基化紊乱的新认识。
Mol Genet Genomic Med. 2024 May;12(5):e2445. doi: 10.1002/mgg3.2445.
4
Personalized Versus Precision Nanomedicine for Treatment of Ovarian Cancer.个体化与精准纳米医学治疗卵巢癌。
Small. 2024 Oct;20(41):e2307462. doi: 10.1002/smll.202307462. Epub 2024 Feb 11.
5
Nanodelivery systems: An efficient and target-specific approach for drug-resistant cancers.纳米递送系统:一种针对耐药性癌症的高效且靶向性方法。
Cancer Med. 2023 Sep;12(18):18797-18825. doi: 10.1002/cam4.6502. Epub 2023 Sep 5.
6
Niosomes Functionalized with a Synthetic Carbohydrate Binding Agent for Mannose-Targeted Doxorubicin Delivery.用合成碳水化合物结合剂功能化的脂质体用于甘露糖靶向阿霉素递送
Pharmaceutics. 2023 Jan 10;15(1):235. doi: 10.3390/pharmaceutics15010235.
7
Insights on the Dynamic Innovative Tumor Targeted-Nanoparticles-Based Drug Delivery Systems Activation Techniques.动态创新肿瘤靶向纳米粒子药物输送系统激活技术的见解。
Int J Nanomedicine. 2022 Dec 7;17:6131-6155. doi: 10.2147/IJN.S386037. eCollection 2022.
8
Gastrointestinal Tract Stabilized Protein Delivery Using Disulfide Thermostable Exoshell System.利用二硫键热稳定外壳系统稳定胃肠道蛋白递释。
Int J Mol Sci. 2022 Aug 30;23(17):9856. doi: 10.3390/ijms23179856.
9
Plant lectins as prospective antiviral biomolecules in the search for COVID-19 eradication strategies.植物凝集素作为有前景的抗病毒生物分子在寻找 COVID-19 根除策略中的应用。
Biomed Pharmacother. 2022 Feb;146:112507. doi: 10.1016/j.biopha.2021.112507. Epub 2021 Dec 7.
10
The Two Sweet Sides of Janus Lectin Drive Crosslinking of Liposomes to Cancer Cells and Material Uptake.Janus 凝集素的双重甜味促使脂质体与癌细胞交联和物质摄取。
Toxins (Basel). 2021 Nov 9;13(11):792. doi: 10.3390/toxins13110792.